tetradecanoylphorbol acetate has been researched along with ml-3000 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Boileau, C; Fahmi, H; Laufer, S; Lavigne, M; Martel-Pelletier, J; Pelletier, JP; Tardif, G | 1 |
Chamorro-Cevallos, GA; Cristobal-Luna, JM; Delgado, F; Escalante, CH; Esquivel-Campos, AL; Gómez-García, O; Gutiérrez-Rebolledo, GA; Hernández-Benitez, RI; Madrigal, DA; Pérez-Gutiérrez, S; Tamariz, J | 1 |
2 other study(ies) available for tetradecanoylphorbol acetate and ml-3000
Article | Year |
---|---|
The regulation of human MMP-13 by licofelone, an inhibitor of cyclo-oxygenases and 5-lipoxygenase, in human osteoarthritic chondrocytes is mediated by the inhibition of the p38 MAP kinase signalling pathway.
Topics: Acetates; Aged; Cells, Cultured; Chondrocytes; Collagenases; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Humans; Interleukin-1; Lipoxygenase Inhibitors; MAP Kinase Signaling System; Matrix Metalloproteinase 13; Middle Aged; Osteoarthritis, Knee; Promoter Regions, Genetic; Pyrroles; Signal Transduction; Tetradecanoylphorbol Acetate; Transcription, Genetic | 2005 |
Synthesis and highly potent anti-inflammatory activity of licofelone- and ketorolac-based 1-arylpyrrolizin-3-ones.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cell Line; Cell Survival; Dose-Response Relationship, Drug; Edema; Ketorolac; Lipopolysaccharides; Macrophages; Male; Mice; Molecular Docking Simulation; Molecular Structure; Nitric Oxide; Pyrroles; Structure-Activity Relationship; Tetradecanoylphorbol Acetate | 2019 |